Insmed Inc (INSM)
24.80
-1.38
(-5.29%)
USD |
NASDAQ |
Apr 18, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Insmed Free Cash Flow: -549.54M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -549.54M |
| September 30, 2023 | -524.40M |
| June 30, 2023 | -475.63M |
| March 31, 2023 | -453.16M |
| December 31, 2022 | -410.32M |
| September 30, 2022 | -387.75M |
| June 30, 2022 | -374.27M |
| March 31, 2022 | -347.99M |
| December 31, 2021 | -370.59M |
| September 30, 2021 | -353.62M |
| June 30, 2021 | -336.11M |
| March 31, 2021 | -295.02M |
| December 31, 2020 | -226.17M |
| September 30, 2020 | -215.30M |
| June 30, 2020 | -222.85M |
| March 31, 2020 | -275.66M |
| December 31, 2019 | -292.92M |
| September 30, 2019 | -310.39M |
| June 30, 2019 | -310.77M |
| March 31, 2019 | -277.89M |
| December 31, 2018 | -272.79M |
| September 30, 2018 | -247.80M |
| June 30, 2018 | -219.14M |
| March 31, 2018 | -198.07M |
| December 31, 2017 | -162.62M |
| Date | Value |
|---|---|
| September 30, 2017 | -171.43M |
| June 30, 2017 | -165.03M |
| March 31, 2017 | -158.12M |
| December 31, 2016 | -150.91M |
| September 30, 2016 | -120.13M |
| June 30, 2016 | -112.73M |
| March 31, 2016 | -108.12M |
| December 31, 2015 | -104.15M |
| September 30, 2015 | -90.67M |
| June 30, 2015 | -89.61M |
| March 31, 2015 | -82.93M |
| December 31, 2014 | -69.77M |
| September 30, 2014 | -69.47M |
| June 30, 2014 | -62.15M |
| March 31, 2014 | -49.10M |
| December 31, 2013 | -47.49M |
| September 30, 2013 | -42.41M |
| June 30, 2013 | -35.12M |
| March 31, 2013 | -37.00M |
| December 31, 2012 | -31.30M |
| September 30, 2012 | -28.70M |
| June 30, 2012 | -27.98M |
| March 31, 2012 | -31.74M |
| December 31, 2011 | -31.18M |
| September 30, 2011 | -33.61M |
Free Cash Flow Range, Past 5 Years
-549.54M
Minimum
Dec 2023
-215.30M
Maximum
Sep 2020
-354.34M
Average
-347.99M
Median
Mar 2022
Free Cash Flow Benchmarks
| NeuroMetrix Inc | -6.268M |
| Intra-Cellular Therapies Inc | -124.47M |
| Rhythm Pharmaceuticals Inc | -136.20M |
| Amylyx Pharmaceuticals Inc | 10.68M |
| AN2 Therapeutics Inc | -53.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -130.82M |
| Cash from Investing (Quarterly) | 1.803M |
| Cash from Financing (Quarterly) | 123.26M |
| Free Cash Flow Per Share (Quarterly) | -0.918 |
| Free Cash Flow to Equity (Quarterly) | -140.77M |
| Free Cash Flow to Firm (Quarterly) | -112.08M |
| Free Cash Flow Yield | -15.78% |